adamantane has been researched along with Endomyocardial Fibrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayami, N; Iwasaki, YK; Murakawa, Y; Sekiguchi, A; Yamashita, T | 1 |
1 other study(ies) available for adamantane and Endomyocardial Fibrosis
| Article | Year |
|---|---|
No Additional Effect of DPP-4 Inhibitor on Preventing Atrial Fibrosis in Streptozotocin-Induced Diabetic Rat as Compared With Sulfonylurea.
Topics: Adamantane; Animals; Anti-Inflammatory Agents; Atrial Fibrillation; Diabetes Mellitus, Experimental; Dipeptidyl-Peptidase IV Inhibitors; Endomyocardial Fibrosis; Female; Glyburide; Heart Atria; Hypoglycemic Agents; Immunohistochemistry; Inflammation; Nitriles; Pyrrolidines; Rats; Rats, Wistar; Statistics as Topic | 2016 |